News Alzheimer's drug Leqembi launched in first EU markets Germany and Austria are the first countries in the EU to see the launch of Leqembi, Eisai and Biogen's much-delayed treatment for Alzheimer's.
News Healthcare bills to pay? Let hi.health pick up the tab Just over a year ago, hi.health launched an app that takes the legwork out of submitting reimbursement claims to private health insurers.
Partner Content Partner Content Anthill extends its presence in DACH region Anthill, a digital communications agency focused on the life science industry, is expanding its services for local clients based in Germany, Austria and Switzerland.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.